Inhibition of glutamate release by cilnidipine in rat cerebrocortical nerve terminals (synaptosomes)

Neuroreport
Cheng Wei LuSu Jane Wang

Abstract

Cilnidipine is an antihypertensive drug that was reported to have a neuroprotective profile. The present study aimed to investigate the effect of cilnidipine on the 4-aminopyridine (4-AP)-induced glutamate release in the rat cerebral cortex using isolated nerve terminals (synaptosomes). Cilnidipine reduced the release of glutamate release induced by 4-AP in a concentration-dependent manner. This inhibitory effect was associated with a reduction in the 4-AP-induced intrasynaptosomal Ca concentration elevation and was not because of an alteration of the synaptosomal membrane potential. The inhibition of glutamate release by cilnidipine was markedly reduced or eliminated in the presence of the Cav2.2 (N-type) and Cav2.1 (P/Q-type) channel blocker ω-conotoxin MVIIC and the protein kinase A inhibitor H89. The intracellular Ca-release inhibitors dantrolene and CGP37157, the mitogen-activated protein kinase inhibitor PD98059 or the protein kinase C inhibitor GF109203X failed to affect the action of cilnidipine. These results suggest that cilnidipine inhibits glutamate release from rat cortical synaptosomes through the suppression of presynaptic voltage-dependent Ca entry and protein kinase A activity.

References

Jun 19, 1986·Nature·D G Nicholls, T S Sihra
Jul 1, 1995·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·D SauerP R Allegrini
Jul 1, 1995·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·S TakizawaY Shinohara
Aug 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·K ValentinoR Ciaranello
May 1, 1997·Trends in Neurosciences·L G Wu, P Saggau
Feb 5, 1999·Progress in Brain Research·D G Nicholls
Nov 19, 2003·Journal of Neurochemistry·Carmelo MillánJosé Sánchez-Prieto
Aug 13, 2008·Neuroreport·Su-Jane WangChia-Yu Huang
Jun 27, 2012·Journal of Neurochemistry·Yuniesky Andrade-TalaveraAntonio Rodríguez-Moreno
Dec 25, 2013·Drug Metabolism and Pharmacokinetics·Kentaro YanoTakuo Ogihara

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.